Is BMEA or BMRN more undervalued in 2026?

CirclFi compares Biomea Fusion, Inc. (BMEA) and BioMarin Pharmaceutical Inc. (BMRN) using 13 institutional-grade valuation models. BMEA has a Quality of Company score of 4.0/10 while BMRN scores 9.2/10.

Which is a better buy — BMEA or BMRN?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do BMEA and BMRN valuations compare?

BMEA at $1.38 and BMRN at $57.29 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

BMEA vs BMRN Valuation Comparison 2026 — Intrinsic Value Analysis

BMEA

Pharmaceutical Preparations

Biomea Fusion, Inc.

Quality

4.0

out of 10

Value Trap

SAFE

Price

$1.38

Last close

Models

9/13

Active

BMRN

Pharmaceutical Preparations

BioMarin Pharmaceutical Inc.

Quality

9.2

out of 10

Value Trap

—

Price

$57.29

Last close

Models

13/13

Active

Model-by-Model Comparison

Model	Type	BMEA Fair Value	BMEA Upside	BMRN Fair Value	BMRN Upside
Bayesian DCF	Intrinsic	$0.50	-63.7%	$29.06	-49.3%
Earnings Power Value	Intrinsic	$1.22	-10.6%	$21.17	-63.0%
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
Markov DDM	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%
RCMH-DCF	Intrinsic	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for BMEA vs BMRN — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

BMEA vs BMRN — Which Stock Is More Undervalued?

BMRN scores higher with a 9.2/10 quality rating vs BMEA's 4.0/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Biomea Fusion, Inc. (BMEA) and BioMarin Pharmaceutical Inc. (BMRN) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

BMEA currently trades at $1.38 with a QOC of 4.0/10, while BMRN trades at $57.29 with a QOC of 9.2/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).